Brief: Medivir: European Commission Grants Orphan Medicinal Product Designation In EU For MIV-818
25/06/2020 07:34
June 25 (Reuters) - Medivir AB MVIRb.ST :
* THE EUROPEAN COMMISSION HAS GRANTED ORPHAN MEDICINAL
PRODUCT
DESIGNATION IN THE EU FOR MIV-818
* EMA GRANTED ORPHAN MEDICINAL PRODUCT DESIGNATION IN EU FOR
MIV-818 FOR TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA
* DESIGNATION CAN GIVE ACCESS TO SEVERAL INCENTIVES,
INCLUDING
PROTOCOL ASSISTANCE, EU CENTRALIZED AUTHORIZATION PROCEDURE AND
REDUCED REGULATORY FEES AND A POTENTIAL FOR A 10-YEAR MARKET
EXCLUSIVITY IN EU
Source text for Eikon: ID:nWkr1XHz5l
Further company coverage: MVIRb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))